|
|
|
|
|
|
Array Biopharma Inc (ARRY)
|
|
9.07 +0.31 (+3.54%)
|
6/23/2017 4:00pm
|
|
Open:
|
8.76
|
Pre. Close:
|
8.76
|
|
High:
|
9.10
|
Low:
|
8.59
|
|
Volume:
|
7,402,869
|
Market Cap:
|
1.55B
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
9.23 - 9.36
|
9.36 - 9.61
|
|
Low:
|
8.25 - 8.35
|
8.35 - 8.53
|
|
Close:
|
8.84 - 9.02
|
9.02 - 9.37
|
|
|
|
|
|
|
Technical analysis (as of: 2017-06-23 4:32:10 PM)
|
|
Overall:
|
|
|
Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.
|
|
Target:
|
Six months: 10.63 One year: 12.41
|
|
Support:
|
Support1: 8.07 Support2: 7.43
|
|
Resistance:
|
Resistance1:
9.10 Resistance2: 10.63
|
|
Pivot:
|
8.04 
|
|
Moving Averages:
|
MA(5): 8.58 MA(20): 8.04
MA(100): 9.31  MA(250): 7.38
|
|
MACD:
|
MACD(12,26):
0.12 Signal(12,26,9): -0.04
|
|
%K %D:
|
%K(14,3): 92.42 %D(3): 81.35
|
|
RSI:
|
RSI(14): 63.25
|
|
52-Week:
|
High: 13.40
Low: 3.10 Change(%): 153.1
|
|
Average Vol(K):
|
3-Month: 242192
10-Days 2886
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.ARRY has closed above the upper band by 1.3%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 3.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
Mon, 05 Jun 2017 21:45:00 GMT
Why Array BioPharma Inc. Sank 13.5% in May
Wed, 31 May 2017 07:02:33 GMT
Array BioPharma And Ono Pharmaceutical Co., Ltd. Announce A License ...
Tue, 30 May 2017 22:22:46 GMT
Bristol-Myers Hookup Boosts Array BioPharma
Sat, 24 Jun 2017 21:56:15 GMT
Stock Alert: Array BioPharma Inc Stock Volatility Hits A Deteriorated Level
Tue, 20 Jun 2017 19:07:30 GMT
Array BioPharma Inc. (ARRY) closes -37.31% below Target Price
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
